Jack Wahlen

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial

W. Hagopian, S. Pillemer, S. Aronoff, 2011, The Lancet.

Non‐adjunctive continuous glucose monitoring for control of hypoglycaemia (COACH): Results of a post‐approval observational study

S. Aronoff, B. Bode, L. Billings, 2021, Diabetic medicine : a journal of the British Diabetic Association.